Metraipolis › archive › dc_2675bb22e3ec

Disproportionality analysis of sex-stratified adverse event signals in growth impairment: Insights from the FDA adverse event reporting system — Europe PMC PMID:42470033

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42470033
DOI
10.1097/md.0000000000049802
License (as archived)
solo-consultazione
Archived
2026-10-08T09:43:59.355Z
SHA-256 of the archived text
6578211a36ec3a2121e338e31606f1c39b1a871ccd2abf956cd90fb7e568f123
Stable URL of this page
https://metraipolis.com/documento/dc_2675bb22e3ec

How to cite

Disproportionality analysis of sex-stratified adverse event signals in growth impairment: Insights from the FDA adverse event reporting system — Europe PMC PMID:42470033 — Europe PMC (en), https://europepmc.org/article/MED/42470033 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2675bb22e3ec (Metraipolis archive dc_2675bb22e3ec, sha256 6578211a36ec3a2121e338e31606f1c39b1a871ccd2abf956cd90fb7e568f123)
BibTeX
@misc{dc2675bb22e3ec,
  title = {Disproportionality analysis of sex-stratified adverse event signals in growth impairment: Insights from the FDA adverse event reporting system — Europe PMC PMID:42470033},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42470033},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2675bb22e3ec; sha256 6578211a36ec3a2121e338e31606f1c39b1a871ccd2abf956cd90fb7e568f123},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42470033. Agents can read the archived copy with the MCP tool read_document.